These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15009453)

  • 1. Cross-linked gamma-chains in fibrin fibrils bridge transversely between strands: no.
    Weisel JW
    J Thromb Haemost; 2004 Mar; 2(3):394-9. PubMed ID: 15009453
    [No Abstract]   [Full Text] [Related]  

  • 2. Cross-linked gamma-chains in a fibrin fibril are situated transversely between its strands.
    Weisel JW
    J Thromb Haemost; 2004 Aug; 2(8):1467-9; discussion 1469-73. PubMed ID: 15304056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-linked gamma-chains in fibrin fibrils bridge 'transversely' between strands: yes.
    Mosesson MW
    J Thromb Haemost; 2004 Mar; 2(3):388-93. PubMed ID: 15009452
    [No Abstract]   [Full Text] [Related]  

  • 4. The covalent structure of factor XIIIa crosslinked fibrinogen fibrils.
    Mosesson MW; Siebenlist KR; Hainfeld JF; Wall JS
    J Struct Biol; 1995; 115(1):88-101. PubMed ID: 7577232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of the topology of factor XIIIa-induced fibrin gamma-chain cross-links by electron microscopy of ligated fragments.
    Weisel JW; Francis CW; Nagaswami C; Marder VJ
    J Biol Chem; 1993 Dec; 268(35):26618-24. PubMed ID: 7902838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal orientation of cross-linked polypeptide γ chains in fibrin fibrils.
    Rosenfeld MA; Leonova VB; Bychkova AV; Kostanova EA; Biryukova MI
    Dokl Biochem Biophys; 2015; 464():286-9. PubMed ID: 26518549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of thrombin-catalyzed fibrin polymerization and factor XIIIa-catalyzed cross-linking of fibrin among three recombinant variant fibrinogens, gamma 275C, gamma 275H, and gamma 275A.
    Hirota-Kawadobora M; Terasawa F; Suzuki T; Tozuka M; Sano K; Okumura N
    J Thromb Haemost; 2004 Aug; 2(8):1359-67. PubMed ID: 15304042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biophysical Mechanisms Mediating Fibrin Fiber Lysis.
    Hudson NE
    Biomed Res Int; 2017; 2017():2748340. PubMed ID: 28630861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The location of the carboxy-terminal region of gamma chains in fibrinogen and fibrin D domains.
    Mosesson MW; Siebenlist KR; Meh DA; Wall JS; Hainfeld JF
    Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10511-6. PubMed ID: 9724734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of respective lysine donor and glutamine acceptor sites involved in factor XIIIa-catalyzed fibrin α chain cross-linking.
    Wang W
    J Biol Chem; 2011 Dec; 286(52):44952-64. PubMed ID: 22030394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive cross-linking of fibrin gamma chains increases resistance to fibrinolysis.
    Siebenlist KR; Mosesson MW
    J Biol Chem; 1994 Nov; 269(45):28414-9. PubMed ID: 7961782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-assembly of soluble unlinked and cross-linked fibrin oligomers.
    Rosenfeld MA; Leonova VB; Biryukova MI; Vasileva MV
    Biochemistry (Mosc); 2011 Oct; 76(10):1155-63. PubMed ID: 22098241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compaction of fibrin clots reveals the antifibrinolytic effect of factor XIII.
    Rijken DC; Abdul S; Malfliet JJ; Leebeek FW; Uitte de Willige S
    J Thromb Haemost; 2016 Jul; 14(7):1453-61. PubMed ID: 27148673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinogen assembly and crosslinking on a fibrin fragment E template.
    Mosesson MW; Siebenlist KR; Hernandez I; Wall JS; Hainfeld JF
    Thromb Haemost; 2002 Apr; 87(4):651-8. PubMed ID: 12008948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The structure and biological features of fibrinogen and fibrin.
    Mosesson MW; Siebenlist KR; Meh DA
    Ann N Y Acad Sci; 2001; 936():11-30. PubMed ID: 11460466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass spectrometry-based molecular mapping of native FXIIIa cross-links in insoluble fibrin clots.
    Schmitt LR; Henderson R; Barrett A; Darula Z; Issaian A; D'Alessandro A; Clendenen N; Hansen KC
    J Biol Chem; 2019 May; 294(22):8773-8778. PubMed ID: 31028172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional analysis of fibrin {gamma}-chain cross-linking by activated factor XIII: determination of a cross-linking pattern that maximizes clot stiffness.
    Standeven KF; Carter AM; Grant PJ; Weisel JW; Chernysh I; Masova L; Lord ST; Ariëns RA
    Blood; 2007 Aug; 110(3):902-7. PubMed ID: 17435113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orientation of the carboxy-terminal regions of fibrin gamma chain dimers determined from the crosslinked products formed in mixtures of fibrin, fragment D, and factor XIIIa.
    Siebenlist KR; Meh DA; Wall JS; Hainfeld JF; Mosesson MW
    Thromb Haemost; 1995 Oct; 74(4):1113-9. PubMed ID: 8560422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a synthetic carboxy-terminal peptide of alpha(2)-antiplasmin on urokinase-induced fibrinolysis.
    Lee KN; Jackson KW; McKee PA
    Thromb Res; 2002 Feb; 105(3):263-70. PubMed ID: 11927133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Position of gamma-chain carboxy-terminal regions in fibrinogen/fibrin cross-linking mixtures.
    Siebenlist KR; Meh DA; Mosesson MW
    Biochemistry; 2000 Nov; 39(46):14171-5. PubMed ID: 11087365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.